We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Compact Generation Flow Cytometers Offer Total Workflow Solution

By LabMedica International staff writers
Posted on 30 Jul 2009
Compact, affordable flow cytometers offer a total workflow solution that will include optimized reagent kits for clinical and life science applications, as well as in-field service. More...
The new flow cytometers will permit laboratory personnel to conduct analyses at their benchtops.

The new guava easyCyteT 8HT flow cytometry system is a compact, six-color detection system with 96-well automation. Six targets and eight parameters can be simultaneously analyzed in a single sample of cells. The system allows freedom to choose fluorescent dyes with well-separated emission spectra, which reduces the chance of overlap in the resulting signals and improves data quality.

The easyCyte 8HT system utilizes microcapillary technology that reduces the number of cells needed for analysis and the amount of waste generated--from liters per day with traditional approaches to less than 50 mL per day. Elimination of complicated fluidics gives the instrument a small footprint and dramatically decreases user maintenance.

The InCyte software allows investigators to view, compare, and analyze up to eight data sets simultaneously. This means that entire plates of data can be analyzed in less time than it currently takes to analyze data from a single sample using traditional software.

The new generation Guava easyCyteT 8HT flow cytometry system was launched by Millipore Corp. (Billerica, MA, USA) a provider of technologies, tools, and services for the global life science industry. It is the first instrument introduced by Millipore since its acquisition of Guava Technologies, a provider of benchtop flow cytometers, in February 2009.

Related Links:
Millipore Corp.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.